Homepage
PR Newswire
14-11-2022, 07:39 PM
This is not exactly a good time to launch a product from the SZSE-SGX ETF link (with all the bad news coming out of China). But the increasing (easier) access for local Spore investors is welcomed.
As usual, the most important thing one should look at, ie the Mgt fees - Currently 0.50% p.a.; Maximum 2% p.a.
SGX Securities welcomes the listing of UOBAM Ping An ChiNext ETF
SGX Securities today welcomed the listing of the UOBAM Ping An ChiNext ETF, managed by UOB Asset Management Ltd (UOBAM). The ETF offers investors access to the ChiNext market which hosts leading innovative and fast-growing companies in Mainland China.
The UOBAM Ping An ChiNext ETF seeks to replicate the performance of the ChiNext Index by investing into the Ping An ChiNext ETF, which is listed on SZSE and is managed by Ping An Fund Management Co Ltd. The ChiNext Index is the benchmark and flagship Index of the ChiNext market and comprises the 100 largest and most liquid A-shares listed on the market.
https://links.sgx.com/FileOpen/20221114-...eID=738631
Product page: https://www.uobam.com.sg/our-funds/highl...index.page
As usual, the most important thing one should look at, ie the Mgt fees - Currently 0.50% p.a.; Maximum 2% p.a.
SGX Securities welcomes the listing of UOBAM Ping An ChiNext ETF
SGX Securities today welcomed the listing of the UOBAM Ping An ChiNext ETF, managed by UOB Asset Management Ltd (UOBAM). The ETF offers investors access to the ChiNext market which hosts leading innovative and fast-growing companies in Mainland China.
The UOBAM Ping An ChiNext ETF seeks to replicate the performance of the ChiNext Index by investing into the Ping An ChiNext ETF, which is listed on SZSE and is managed by Ping An Fund Management Co Ltd. The ChiNext Index is the benchmark and flagship Index of the ChiNext market and comprises the 100 largest and most liquid A-shares listed on the market.
https://links.sgx.com/FileOpen/20221114-...eID=738631
Product page: https://www.uobam.com.sg/our-funds/highl...index.page